Type 2 Diabetes clinical trials
Showing 201–250 of 391 active trials. Describe your situation to see which ones you may be eligible for.
- Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
- PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAG
- Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility
- NYSCF Scientific Discovery Biobank
- Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis
- SGLTi, Hepatic Glucose Production and Ketogenesis
- SGLT2i, Pioglitazone, and Ketone Production in T2D
- SGLT2i, Hepatic Glucose Production, and SNS
- SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia
- LINK-IT: Leveraging vIdeos and commuNity Health worKers to Improve Diabetes OuTcomes
- OASIS: Peer Support for T2DM in Appalachia (Peer Coaches)
- GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
- Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Type 2 Diabetes Patients Treated With Incretin Mimetics
- Glucose and Activity Tracking for Sedentary Behavior Interventions in Older People With Type 2 Diabetes (TRACK T2D)
- Virtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin Therapy
- Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis
- Achieving Routine Intervention and Screening for Emotional Health
- Pilot-Testing Strategies to Improve Outcomes for Youth With Type 2 Diabetes by Addressing Health-Related Social Needs
- Balance Control and Recovery in Diabetes Peripheral Neuropathy
- Digital Health Navigation for Latino Patients With Type II Diabetes
- Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
- Implementation of Team Clinic for Type 2 Diabetes (TCT2)
- Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM)
- Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
- Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
- SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan
- Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction
- Use of CGM in Kidney Transplant Recipients
- Role of KATP Channel Loss in Type 2 Diabetes
- Diabetes Learning in Virtual Environments Just in Time for Community Reentry
- Ketones, SGLT2, HFrEF
- Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification
- Improving Diabetes Care With Strategies For Addressing Health-Related Social Needs and Community Partnerships
- Arginine Metabolism in Youth With Type 2 Diabetes
- Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life
- The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
- Novel Digital Patient-Reported Outcomes Tool for Diabetes Management
- My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes
- Phenotyping Genetic Risk for Type 2 Diabetes
- Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)
- Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes
- Food Insecurity Reduction & Strategy Team
- Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals
- Sleep and Glycemic Control in Type 2 Diabetes Adolescents
- Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
- Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease
- Mechanisms of Ultrasound Neuromodulation Effects in Diabetes
- IH, Brain Health, and T2D
- Promoting Intergenerational Health in Rural Kentuckians With Diabetes (PIHRK'D)
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.